Private placement in Devyser Diagnostics AB (SE) — SEK 130 million

Carnegie acted as sole financial advisor in the private placement raising gross proceeds of SEK 130 million. Devyser develops, manufactures and sells genetic tests to laboratories in over 60 countries. The products are used for complex DNA testing in oncology, transplantation and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases and follow-up of transplant patients.
February 2021.